12:00 AM
May 28, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Tefina: Phase II started

Trimel began a double-blind, placebo-controlled, international Phase II trial to evaluate Tefina in 240 premenopausal women.

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >